Structure-Function Correlation of Retinal Fibrosis in Eyes with Neovascular Age-Related Macular Degeneration

Structure-Function Correlation of Retinal Fibrosis in Eyes with Neovascular Age-Related Macular Degeneration

<b>Purpose:</b> To assess retinal function in areas of presumed fibrosis due to neovascular age-related macular degeneration (nAMD), using multimodal imaging and structure-function correlation. <b>Design:</b> Cross-sectional observational study. <b>Methods:</b> 30...

Full description

Bibliographic Details
Main Authors:	Markus Schranz, Stefan Sacu, Gregor S. Reiter, Magdalena Baratsits, Silvia Desissaire, Michael Pircher, Georgios Mylonas, Christoph Hitzenberger, Ursula Schmidt-Erfurth, Philipp Ken Roberts
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Journal of Clinical Medicine
Subjects:	nAMD fibrosis multimodal imaging microperimetry
Online Access:	https://www.mdpi.com/2077-0383/13/4/1074

Similar Items

Effect of COVID-19 Lockdown in Spain on Structural and Functional Outcomes of Neovascular AMD Patients
by: Alicia Valverde-Megías, et al.
Published: (2021-08-01)

Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients
by: Eleonora M. Lad, MD, PhD, et al.
Published: (2022-09-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
by: Sanjay Kumar Mishra, et al.
Published: (2022-07-01)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
by: Prem Patel, et al.
Published: (2021-05-01)

Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis
by: Christof Hänsli, et al.
Published: (2023-03-01)

Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration
by: Joseph M. Coney, et al.
Published: (2023-02-01)

Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
by: Ryan Zubricky, et al.
Published: (2023-06-01)

Two-Photon Vision in Age-Related Macular Degeneration: A Translational Study
by: Grzegorz Łabuz, et al.
Published: (2022-03-01)

Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
by: Justus G. Garweg, et al.
Published: (2023-01-01)

Long-Term Consequences of COVID-19 Lockdown in Neovascular AMD Patients in Spain: Structural and Functional Outcomes after 1 Year of Standard Follow-Up and Treatment
by: Daniela Rego-Lorca, et al.
Published: (2022-08-01)

Experimental Models in Neovascular Age Related Macular Degeneration
by: Olivia Rastoin, et al.
Published: (2020-06-01)

Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study
by: Chakraborty D, et al.
Published: (2023-08-01)

Defining the structure–function relationship of specific lesions in early and advanced age-related macular degeneration
by: Ting Fang Tan, et al.
Published: (2024-04-01)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
by: Deepali R Damkondwar, et al.
Published: (2022-01-01)

Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis
by: Ching-Yao Tsai, et al.
Published: (2023-01-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

Age-Related Macular Degeneration Staging by Color Fundus Photography vs. Multimodal Imaging—Epidemiological Implications (<i>The Coimbra Eye Study—Report 6</i>)
by: Cláudia Farinha, et al.
Published: (2020-05-01)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
by: Varsha Pramil, et al.
Published: (2021-10-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
by: İmren Akkoyun
Published: (2014-12-01)

Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration
by: Radina Kirkova, et al.
Published: (2022-09-01)

Severity of age-related macular degeneration at first presentation in Bhutan: a 3-year national study
by: Bhim B. Rai, et al.
Published: (2022-07-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Ashwin Gupta, et al.
Published: (2022-01-01)

Cell-specific Systemic Immune Signatures Associated with Treatment Burden in Neovascular Age-related Macular Degeneration
by: Joseph B. Lin, BS, et al.
Published: (2024-03-01)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
by: Tan CS, et al.
Published: (2022-03-01)

Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence
by: Hrvoje Bogunović, et al.
Published: (2022-08-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
by: Sonali Nashine
Published: (2021-09-01)

Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
by: Lucia Finocchio, et al.
Published: (2023-12-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
by: Ngoc Thien Le, et al.
Published: (2023-12-01)

Fixation Stability and Preferred Retinal Locus in Advanced Age-Related Macular Degeneration
by: Deniz Altınbay, et al.
Published: (2022-02-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
by: M. M. Bikbov, et al.
Published: (2022-03-01)

Dysregulated Tear Film Proteins in Macular Edema Due to the Neovascular Age-Related Macular Degeneration Are Involved in the Regulation of Protein Clearance, Inflammation, and Neovascularization
by: Mateusz Winiarczyk, et al.
Published: (2021-07-01)

LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration
by: Lucia Mundo, et al.
Published: (2021-08-01)

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
by: Eleonora M. Lad, et al.
Published: (2023-09-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
by: Mayank Choubey, et al.
Published: (2023-11-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
by: Yujong Yi, et al.
Published: (2024-03-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
by: Omar A. Halawa, et al.
Published: (2021-06-01)

Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration: Case Series
by: Filomena Palmieri, et al.
Published: (2023-03-01)

Proteins Associated with Phagocytosis Alteration in Retinal Pigment Epithelial Cells Derived from Age-Related Macular Degeneration Patients
by: Audrey Voisin, et al.
Published: (2022-04-01)

Evaluation of the macular sensitivity and retinal ganglion cell layer in unilateral amblyopia
by: Nilay Çiçek, et al.
Published: (2024-01-01)